PubRank

Kazutaka Kurokohchi

Author PubWeight™ 31.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Hepatology 2004 1.48
2 Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol 2008 1.33
3 Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 2003 1.31
4 Paraneoplastic necrotizing myelopathy in a patient with advanced esophageal cancer: An autopsied case report. J Neurol Sci 2009 1.00
5 Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. Int J Oncol 2002 0.93
6 Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Int J Oncol 2005 0.93
7 Enlargement of thermal ablation zone by the combination of ethanol injection and radiofrequency ablation in excised bovine liver. Int J Oncol 2004 0.91
8 Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model. Int J Mol Med 2007 0.91
9 Intravascular large B-cell lymphoma with FDG accumulation in the lung lacking CT/(67)gallium scintigraphy abnormality. Hematol Oncol 2009 0.90
10 Use of protein array to investigate receptor tyrosine kinases activated in gastric cancer. Int J Oncol 2010 0.89
11 Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Ann Surg Oncol 2008 0.89
12 Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma. Int J Oncol 2002 0.87
13 Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Int J Oncol 2005 0.87
14 Fulminant hepatic failure caused by malignant melanoma of unknown primary origin. J Gastroenterol 2004 0.85
15 A rare case of hepatocellular carcinoma accompanied by metastasis of a cervical lymph node. Intern Med 2012 0.83
16 Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A. J Autoimmun 2007 0.81
17 Coexistence of splenic non-Hodgkin's lymphoma with hepatocellular carcinoma in a patient with chronic hepatitis C. Dig Dis Sci 2006 0.81
18 Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis. Int J Oncol 2007 0.80
19 The close relationship between life-threatening breathing disorders and urine storage dysfunction in multiple system atrophy. J Neurol 2010 0.80
20 Percutaneous local therapies for hepatocellular carcinoma impair gastric function. World J Gastroenterol 2006 0.80
21 Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma. Hepat Mon 2012 0.79
22 Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease. Diabetol Metab Syndr 2013 0.79
23 Identification of p46 Shc expressed in the nuclei of hepatocytes with high proliferating activity: Study of regenerating rat liver. Int J Mol Med 2004 0.78
24 In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma. Int J Oncol 2005 0.78
25 Enhanced expression of p46 Shc in the nucleus and p52 Shc in the cytoplasm of human gastric cancer. Int J Oncol 2005 0.78
26 Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C. Exp Ther Med 2010 0.78
27 Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats. Int J Oncol 2004 0.78
28 Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats. Int J Mol Med 2004 0.78
29 Activation of c-Yes in hepatocellular carcinoma: a preliminary study. World J Gastroenterol 2006 0.77
30 Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats. Int J Oncol 2004 0.77
31 Multidisciplinary treatment of patients with hepatocellular carcinoma. Expert Rev Anticancer Ther 2006 0.77
32 Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survival. Oncol Rep 2011 0.77
33 Clinical relevance of antibodies to cardiolipin in patients with chronic hepatitis C. J Clin Lab Anal 2012 0.76
34 Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration. Oncol Rep 2005 0.76
35 Safe and efficient transgene expression in rat hepatocytes induced by adenoviral administration into the biliary tract. Oncol Rep 2005 0.76
36 Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases. Can J Gastroenterol 2012 0.75
37 Hepatic von Meyenburg complex: a trigger of severe portal hypertension. Liver Int 2008 0.75
38 Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): a case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma. Oncol Rep 2005 0.75
39 Aldehyde dehydrogenase-2 genotypes and HLA haplotypes in Japanese patients with esophageal cancer. Oncol Rep 2002 0.75
40 Abnormal bile flow in patients with achalasia. J Gastroenterol 2003 0.75
41 A case of acute autoimmune hepatitis presenting after incomplete-type CREST syndrome and chronic thyroiditis. Nihon Shokakibyo Gakkai Zasshi 2014 0.75
42 Enhanced expression of Bcl-2 in lymphocytes infiltrating into the liver of patients with primary biliary cirrhosis. Int J Mol Med 2002 0.75